{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T10:03:38Z","timestamp":1789639418820,"version":"4.0.0"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004562","name":"Ministry of Higher Education and Research","doi-asserted-by":"publisher","award":["ANR-IA-COH-2012\/3731"],"award-info":[{"award-number":["ANR-IA-COH-2012\/3731"]}],"id":[{"id":"10.13039\/501100004562","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014089","name":"Boehringer Ingelheim France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014089","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp & Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007132","name":"Otsuka Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic kidney disease (CKD) leads to the accumulation of uremic toxins (UTs), including tryptophan-derived metabolites such as kynurenine (KYN), indoxyl sulfate (IS), and indole-3-acetic acid (IAA). IS has been identified as a potential contributor to cognitive impairment (CI), whereas less is known about the other tryptophan metabolites. We aimed to evaluate the association between these toxins related to tryptophan metabolism and CI in patients with CKD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Three thousand thirty-three patients with CKD stages 2\u20135 enrolled in CKD\u2013Renal Epidemiology and Information Network (CKD-REIN) cohort. Patients with both UT measurement and cognitive function screening [with mini-mental state examination (MMSE)] were included. CI was defined as an MMSE score\u00a0\u2264\u00a026\/30. Logistic regression was used to assess the association between the studied UTs and MMSE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 2389 included patients [mean (SD) age: 66.5 (12.8) years, 66% males, mean (SD) estimated glomerular filtration rate (eGFR) 34.8 (13.4) ml\/min\/1.73 m2], 858 patients (35.9%) had an MMSE score \u226426\/30. After adjustment for sociodemographic factors, cardiovascular risk factors, cerebrovascular disease, current depression, eGFR, urinary albumin-to-creatinine ratio, and UTs known to be associated with CI, no significant association was found between KYN or IAA and MMSE \u226426\/30, whereas IS was significantly associated [Odds Ratio (OR), 95% confidence interval: 1.11 (1.00\u20131.21)].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Among tryptophan-derived metabolites studied, IS was associated with CI in patients with CKD, in contrast to KYN and IAA. Despite sharing a common origin, the UTs studied follow distinct metabolic pathways with different effects, highlighting the need for further investigation of the tryptophan pathway on CI in CKD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ckj\/sfag199","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:39:55Z","timestamp":1781613595000},"source":"Crossref","is-referenced-by-count":0,"title":["Association of tryptophan metabolites with cognitive impairment in chronic kidney disease"],"prefix":"10.1093","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0837-634X","authenticated-orcid":false,"given":"Gaye","family":"Hafez","sequence":"first","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, UVSQ, INSERM UMRS 1018, Clinical Epidemiology Team, Centre de Recherche en \u00c9pid\u00e9miologie et Sant\u00e9 des Populations (CESP) , Villejuif, Paris ,","place":["France"]},{"name":"Altinbas University Department of Pharmacology, Faculty of Pharmacy, , Istanbul ,","place":["T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5771-5996","authenticated-orcid":false,"given":"Ziad A","family":"Massy","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, UVSQ, INSERM UMRS 1018, Clinical Epidemiology Team, Centre de Recherche en \u00c9pid\u00e9miologie et Sant\u00e9 des Populations (CESP) , Villejuif, Paris ,","place":["France"]},{"name":"Ambroise Par\u00e9 Hospital Department of Nephrology, , Boulogne-Billancourt ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Alvarez","sequence":"additional","affiliation":[{"name":"Raymond Poincar\u00e9 Hospital, AP-HP Department of Pharmacology and Toxicology, , Garches ,","place":["France"]},{"name":"UVSQ, Universit\u00e9 Paris-Saclay, Inserm U1018, CESP, \u00c9quipe MOODS , Garches ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3064-2480","authenticated-orcid":false,"given":"Marion","family":"P\u00e9pin","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, UVSQ, INSERM UMRS 1018, Clinical Epidemiology Team, Centre de Recherche en \u00c9pid\u00e9miologie et Sant\u00e9 des Populations (CESP) , Villejuif, Paris ,","place":["France"]},{"name":"AP-HP, University Hospital Group Paris Saclay, Ambroise Par\u00e9 Hospital , University Medical Department 1; Geriatric Department, Boulogne-Billancourt ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sol\u00e8ne M","family":"Laville","sequence":"additional","affiliation":[{"name":"Amiens University Medical Center Pharmacoepidemiology Unit, Department of Clinical Pharmacology, , Amiens ,","place":["France"]},{"name":"MP3CV Laboratory, EA7517, Jules Verne University of Picardie , Amiens ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0438-6487","authenticated-orcid":false,"given":"Natalia Alencar","family":"de\u00a0Pinho","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, UVSQ, INSERM UMRS 1018, Clinical Epidemiology Team, Centre de Recherche en \u00c9pid\u00e9miologie et Sant\u00e9 des Populations (CESP) , Villejuif, Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Islam Amine","family":"Larabi","sequence":"additional","affiliation":[{"name":"Raymond Poincar\u00e9 Hospital, AP-HP Department of Pharmacology and Toxicology, , Garches ,","place":["France"]},{"name":"UVSQ, Universit\u00e9 Paris-Saclay, Inserm U1018, CESP, \u00c9quipe MOODS , Garches ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5384-9006","authenticated-orcid":false,"given":"Sophie","family":"Liabeuf","sequence":"additional","affiliation":[{"name":"Amiens University Medical Center Pharmacoepidemiology Unit, Department of Clinical Pharmacology, , Amiens ,","place":["France"]},{"name":"MP3CV Laboratory, EA7517, Jules Verne University of Picardie , Amiens ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3666-1407","authenticated-orcid":false,"given":"H\u00e9l\u00e8ne","family":"Levassort","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, UVSQ, INSERM UMRS 1018, Clinical Epidemiology Team, Centre de Recherche en \u00c9pid\u00e9miologie et Sant\u00e9 des Populations (CESP) , Villejuif, Paris ,","place":["France"]},{"name":"AP-HP, University Hospital Group Paris Saclay, Ambroise Par\u00e9 Hospital , University Medical Department 1; Geriatric Department, Boulogne-Billancourt ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"CKD-REIN Study Collaborators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Alencar\u00a0de\u00a0Pinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doroth\u00e9e","family":"Cannet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Combe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Fouque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Frimat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aghil\u00e9s","family":"Hamroun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves-Edouard","family":"Herpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Jacquelinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"Laville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Liabeuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad A","family":"Massy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Pecoits-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"Schanstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Stengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriane","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Metzger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Moutard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"2026091705165311100_bib1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","author":"Bikbov","year":"2020","journal-title":"Lancet"},{"key":"2026091705165311100_bib2","doi-asserted-by":"publisher","first-page":"100438","DOI":"10.1016\/j.lanepe.2022.100438","article-title":"Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2\u00b74 million patients from 11 countries: the CaReMe CKD study","volume":"20","author":"Sundstr\u00f6m","year":"2022","journal-title":"Lancet Regional Health\u2014Europe"},{"key":"2026091705165311100_bib3","doi-asserted-by":"publisher","first-page":"ii55","DOI":"10.1093\/ndt\/gfab261","article-title":"Albuminuria as a risk factor for mild cognitive impairment and dementia\u2014what is the evidence?","volume":"37","author":"Bikbov","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"2026091705165311100_bib4","doi-asserted-by":"crossref","first-page":"ii23","DOI":"10.1093\/ndt\/gfab262","article-title":"Cognitive disorders in patients with chronic kidney disease: specificities of clinical assessment","volume":"37","author":"P\u00e9pin","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"2026091705165311100_bib5","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41581-020-0266-9","article-title":"Mechanisms of cognitive dysfunction in CKD","volume":"16","author":"Viggiano","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"2026091705165311100_bib6","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1046\/j.1523-1755.2003.00924.x","article-title":"Review on uremic toxins: classification, concentration, and interindividual variability","volume":"63","author":"Vanholder","year":"2003","journal-title":"Kidney Int"},{"key":"2026091705165311100_bib7","doi-asserted-by":"publisher","first-page":"II33","DOI":"10.1093\/ndt\/gfab223","article-title":"Chronic kidney disease and neurological disorders: are uraemic toxins the missing piece of the puzzle?","volume":"37","author":"Liabeuf","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"2026091705165311100_bib8","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3390\/toxins14040280","article-title":"Uremic toxins and cardiovascular risk in chronic kidney disease: what have we learned recently beyond the past findings?","volume":"14","author":"El\u00a0Chamieh","year":"2022","journal-title":"Toxins"},{"key":"2026091705165311100_bib9","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.2215\/CJN.03980609","article-title":"Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients","volume":"4","author":"Barreto","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026091705165311100_bib10","first-page":"1","article-title":"Alencar De Pinho N et al. Study of the association between serum levels of kynurenine and cardiovascular outcomes and overall mortality in chronic kidney disease","volume":"17","author":"El\u00a0Chamieh","year":"2024","journal-title":"Clin Kidney J"},{"key":"2026091705165311100_bib11","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1038\/s41467-018-05470-4","article-title":"Microbial tryptophan catabolites in health and disease","volume":"9","author":"Roager","year":"2018","journal-title":"Nat Commun"},{"key":"2026091705165311100_bib12","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1681\/ASN.2013121283","article-title":"The cardiovascular effect of the uremic solute indole-3 acetic acid","volume":"26","author":"Dou","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2026091705165311100_bib13","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.neuro.2016.01.006","article-title":"Indoxyl sulfate, not p-cresyl sulfate, is associated with cognitive impairment in early-stage chronic kidney disease","volume":"53","author":"Yeh","year":"2016","journal-title":"Neurotoxicology"},{"key":"2026091705165311100_bib14","doi-asserted-by":"publisher","first-page":"20388","DOI":"10.1038\/s41598-019-57004-7","article-title":"Protein-bound uremic toxins are associated with cognitive function among patients undergoing maintenance hemodialysis","volume":"9","author":"Lin","year":"2019","journal-title":"Sci Rep"},{"key":"2026091705165311100_bib15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1161\/HYPERTENSIONAHA.120.14759","article-title":"Trimethylamine-N-oxide promotes age-related vascular oxidative stress and endothelial dysfunction in mice and healthy humans","volume":"76","author":"Brunt","year":"2020","journal-title":"Hypertension"},{"key":"2026091705165311100_bib16","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1681\/ASN.2018060609","article-title":"Indoxyl sulfate and p-cresyl sulfate promote vascular calcification and associate with glucose intolerance","volume":"30","author":"Opdebeeck","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"2026091705165311100_bib17","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1002\/jcp.25018","article-title":"Para-cresyl sulfate acutely impairs vascular reactivity and induces vascular remodeling","volume":"230","author":"Gross","year":"2015","journal-title":"J Cell Physiol"},{"key":"2026091705165311100_bib18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/toxins12010010","article-title":"Serum P-cresyl sulfate is a predictor of central arterial stiffness in patients on maintenance hemodialysis","volume":"12","author":"Lai","year":"2019","journal-title":"Toxins"},{"key":"2026091705165311100_bib19","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1016\/j.ekir.2025.05.037","article-title":"Association of phenylacetylglutamine and cognitive impairment in CKD","volume":"10","author":"Levassort","year":"2025","journal-title":"Kidney Int Rep"},{"key":"2026091705165311100_bib20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13195-024-01480-1","article-title":"Plasma trimethylamine N-oxide (TMAO): associations with cognition, neuroimaging, and dementia","volume":"16","author":"Yaqub","year":"2024","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"2026091705165311100_bib21","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1093\/ndt\/gft388","article-title":"The French chronic kidney disease-renal epidemiology and information network (CKD-REIN) cohort study","volume":"29","author":"Stengel","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"2026091705165311100_bib22","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Stevens","year":"2024","journal-title":"Kidney Int"},{"key":"2026091705165311100_bib23","volume-title":"Center for Epidemiologic Studies Depression Scale-Shortened Version","author":"Powers","year":"2022"},{"key":"2026091705165311100_bib24","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.ekir.2025.02.024","article-title":"Uncovering the link between kynurenic acid pathway and kidney failure","volume":"10","author":"El\u00a0Chamieh","year":"2025","journal-title":"Kidney Int Rep"},{"key":"2026091705165311100_bib25","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.cca.2020.04.032","article-title":"Quantification of free and protein-bound uremic toxins in human serum by LC-MS\/MS: comparison of rapid equilibrium dialysis and ultrafiltration","volume":"507","author":"Fabresse","year":"2020","journal-title":"Clin Chim Acta"},{"key":"2026091705165311100_bib26","doi-asserted-by":"publisher","first-page":"CD010783","DOI":"10.1002\/14651858.CD010783.pub3","article-title":"Mini-Mental State Examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI)","volume":"7","author":"Arevalo-Rodriguez","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"2026091705165311100_bib27","doi-asserted-by":"crossref","DOI":"10.1201\/9780429492259","volume-title":"Flexible Imputation of Missing Data, Second Edition","author":"van\u00a0Buuren","year":"2018","edition":"2nd edn"},{"key":"2026091705165311100_bib28","doi-asserted-by":"publisher","first-page":"115467","DOI":"10.1016\/j.bbr.2025.115467","article-title":"Depression in chronic kidney disease: particularities, specific mechanisms and therapeutic considerations, a narrative review","volume":"483","author":"Lefr\u00e8re","year":"2025","journal-title":"Behav Brain Res"},{"key":"2026091705165311100_bib29","doi-asserted-by":"publisher","first-page":"e180229","DOI":"10.1172\/jci.insight.180229","article-title":"Quinolinic acid potentially links kidney injury to brain toxicity","volume":"10","author":"Saliba","year":"2025","journal-title":"JCI Insight"},{"key":"2026091705165311100_bib30","doi-asserted-by":"publisher","first-page":"998","DOI":"10.3390\/biom12070998","article-title":"The role of tryptophan dysmetabolism and quinolinic acid in depressive and neurodegenerative diseases","volume":"12","author":"Hestad","year":"2022","journal-title":"Biomolecules"},{"key":"2026091705165311100_bib31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12882-016-0387-3","article-title":"Tryptophan metabolism, its relation to inflammation and stress markers and association with psychological and cognitive functioning: Tasmanian Chronic Kidney Disease pilot study","volume":"17","author":"Karu","year":"2016","journal-title":"BMC Nephrol"},{"key":"2026091705165311100_bib32","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1093\/cvr\/cvaf106","article-title":"The role of uremic toxin indoxyl sulfate in the pathophysiology of aortic valve stenosis","volume":"121","author":"D\u00fcsing","year":"2025","journal-title":"Cardiovasc Res"},{"key":"2026091705165311100_bib33","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3390\/toxins3070911","article-title":"Protein-bound uremic toxins: new insight from clinical studies","volume":"3","author":"Liabeuf","year":"2011","journal-title":"Toxins"},{"key":"2026091705165311100_bib34","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1681\/ASN.2019070728","article-title":"Uremic toxic blood-brain barrier disruption mediated by AhR activation leads to cognitive impairment during experimental renal dysfunction","volume":"31","author":"Bobot","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"2026091705165311100_bib35","doi-asserted-by":"publisher","first-page":"115693","DOI":"10.1016\/j.bbr.2025.115693","article-title":"Blood-brain barrier permeability in CKD: link with inflammation and cognitive and mood impairment in rats","volume":"493","author":"Bobot","year":"2025","journal-title":"Behav Brain Res"},{"key":"2026091705165311100_bib36","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3904\/kjim.2021.492","article-title":"Emotional and cognitive changes in chronic kidney disease","volume":"37","author":"Kim","year":"2022","journal-title":"Korean J Intern Med"},{"key":"2026091705165311100_bib37","doi-asserted-by":"publisher","first-page":"774","DOI":"10.23876\/j.krcp.23.005","article-title":"Indoxyl sulfate induces apoptotic cell death by inhibiting glycolysis in human astrocytes","volume":"43","author":"Jeong","year":"2024","journal-title":"Kidney Res Clin Pract"},{"key":"2026091705165311100_bib38","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/jcm8020191","article-title":"Indoxyl sulfate induces apoptosis through oxidative stress and mitogen-activated protein kinase signaling pathway inhibition in human astrocytes","volume":"8","author":"Lin","year":"2019","journal-title":"J Clin Med"},{"key":"2026091705165311100_bib39","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.neuro.2019.02.019","article-title":"Indole-3 acetic acid increased risk of impaired cognitive function in patients receiving hemodialysis","volume":"73","author":"Lin","year":"2019","journal-title":"Neurotoxicology"},{"key":"2026091705165311100_bib40","doi-asserted-by":"publisher","first-page":"110747","DOI":"10.1016\/j.neuropharm.2025.110747","article-title":"Indole-3-acetic acid exerts protective effects on sleep deprivation-induced cognitive impairment","volume":"283","author":"Han","year":"2026","journal-title":"Neuropharmacology"},{"key":"2026091705165311100_bib41","doi-asserted-by":"publisher","first-page":"115055","DOI":"10.1016\/j.expneurol.2024.115055","article-title":"Gut microbiota-derived 3-indoleacetic acid confers a protection against sepsis-associated encephalopathy through microglial aryl hydrocarbon receptors","volume":"384","author":"Huang","year":"2025","journal-title":"Exp Neurol"},{"key":"2026091705165311100_bib42","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00109-023-02289-5","article-title":"Activation of aryl hydrocarbon receptor (AhR) in Alzheimer\u2019s disease: role of tryptophan metabolites generated by gut host-microbiota","volume":"101","author":"Salminen","year":"2023","journal-title":"J Mol Med"},{"key":"2026091705165311100_bib43","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00424-023-02884-y","article-title":"Chronic kidney disease may evoke anxiety by altering CRH expression in the amygdala and tryptophan metabolism in rats","volume":"476","author":"Ibos","year":"2024","journal-title":"Pfl\u00fcgers Archiv\u2014Eur J Physiol"},{"key":"2026091705165311100_bib44","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3390\/toxins15020150","article-title":"Correlation between saliva levels and serum levels of free uremic toxins in healthy volunteers","volume":"15","author":"Fabresse","year":"2023","journal-title":"Toxins"},{"key":"2026091705165311100_bib45","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.3390\/cells10061548","article-title":"Neuroinflammation and the Kynurenine Pathway in CNS disease: molecular mechanisms and therapeutic implications","volume":"10","author":"Mithaiwala","year":"2021","journal-title":"Cells"},{"key":"2026091705165311100_bib46","doi-asserted-by":"publisher","first-page":"6328","DOI":"10.3390\/ijms26136328","article-title":"Transporter-mediated interactions between uremic toxins and drugs: a hidden driver of toxicity in chronic kidney disease","volume":"26","author":"Spicher","year":"2025","journal-title":"Int J Mol Sci"},{"key":"2026091705165311100_bib47","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1093\/ndt\/gfad244","article-title":"A new approach for cognitive impairment pattern in chronic kidney disease","volume":"39","author":"Levassort","year":"2024","journal-title":"Nephrol Dial Transplant"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfag199\/68541560\/sfag199.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/7\/sfag199\/68541560\/sfag199.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/7\/sfag199\/68541560\/sfag199.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:17:01Z","timestamp":1789636621000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfag199\/8709801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfag199","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,6,17]]},"article-number":"sfag199"}}